UD professor earns $400K+ for new brain study
University of Dayton biology professor Pothitos M. Pitychoutis, is receiving a grant of $413,681 to study a potential catalyst for conditions such as autism, schizophrenia and ADHD.
The purpose behind the study is to find more effective and safer treatments for these conditions.
'Overall, gaining insights into the regulation of calcium-cycling processes in the brain may pave the way for developing new, safer and more effective drug therapies for the treatment of these debilitating and costly brain disorders,' Pitychoutis said.
Pitychoutis' study will see a closer look at phospholamban, the calcium-handling protein and its impact in the part of the brain that manages sleep, attention and how we process stimuli around us.
The grant will help with Pitychoutis' efforts as well as opportunities available for UD students.
'Working on this project will help prepare some of our talented students to pursue postgraduate studies in neuroscience and follow careers in industry and academia, as well as in biomedical and health-related professions,' Pitychoutis said.
While the university currently hosts a neuroscience minor, the program will expand to serve as a major for students beginning this fall.
For more information on the study and the grant award to Pitychoutis, click here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
9 hours ago
- Associated Press
Bonding Health Introduces Emotional Regulation Score™ – The First Clinical-Grade Tool to Help ADHD Adults and Parents Measure and Build Emotional Mastery
New York, NY - July 22, 2025 - Bonding Health, a innovative digital health company serving individuals and families impacted by ADHD, today announced the launch of its Emotional Regulation Score™, a new clinically validated feature that allows users to measure, develop, and track their ability to regulate their emotions. The new feature will launch on Friday, July 25, as part of Version 4 of the Bonding Health app, on iOS and Android. The Emotional Regulation Score™ (ERS), was developed using the Emotion Regulation Questionnaire (ERQ) which is a well-accepted gold standard in psychological science developed by Gross & John (2003). The ERS brings decades of research into an actionable, mobile-first app experience created exclusively for ADHD brains. 'Emotional regulation has generally been treated as an abstract skill,' said Pen King Jr., CEO of Bonding Health. 'Now with the Emotional Regulation Score™ we are changing the game. For the first time ever, ADHD adults and parents have a way to measure this critically important ability, develop the skill through structured supports, and follow their progress over time, as we do with trackers for physical health.' Addressing a Critical Need in ADHD Support Emotional regulation is one of the most substantial predictors of long-term well-being (just the mind, but the body and relationships). It has ramifications for mental clarity, physical wellness and the quality of relationships both personally and professionally. In order to make improvements in emotional regulation, it is essential to measure it, however there are few specific individuals are able to measure emotional regulation (specifically individuals with ADHD), and furthermore few practices to develop it. Bonding Health's Emotional Regulation Score™ provides a simple, data-driven mechanism to build self-awareness and emotional resilience. Key Features of the Emotional Regulation Score™ Expanding Support Through PKJ Coaching Bonding Health has teamed up with PKJ Coaching, a recognized leader in coaching programs focused on ADHD, to enhance user support. This partnership allows all users to not only learn from their Emotional Regulation Score™ but also receive personalized strategies and accountability to practice these skills in everyday life. Availability The Emotional Regulation Score™ will launch on Friday, July 25, 2025, with Version 4 of the Bonding Health app, available for both iOS and Android. Download now to be first in line: About Bonding Health Bonding Health is a digital health company that supports individuals and families affected by ADHD to achieve a higher degree of emotional balance and resilience. Importantly, Bonding Health offers clinician-designed tools, daily habit trackers, and collective resources such as PKJ Coaching that continue to provide evidence-based resources that allow individuals to thrive rather than focus on medication. Media Contact: Pen King Jr. CEO, Bonding Health [email protected] Media Contact Company Name: Bonding Health Contact Person: Pen King Jr. Email: Send Email State: New York Country: United States Website: Source: AIO Newswire
Yahoo
2 days ago
- Yahoo
I'm A Psychologist – This Is Why Summer Can Be So Hard On Neurodiverse Kids
School's out for summer (or it will be for most kids in England as of tomorrow) – but for neurodivergent children, the disruption in routine can turn their worlds upside down. You might notice more meltdowns and dysregulation – and it's not just your child who will be struggling. It's thought one in 100 children in the UK have a diagnosis of autism spectrum disorder, while 5% of UK children are thought to have ADHD (attention deficit hyperactivity disorder). Dr Selina Warlow, a clinical psychologist and founder of The Nook Clinic, explained that neurodiverse children struggle with the summer holidays because they 'often rely on routine to feel secure'. 'Unstructured days can be disorienting because they remove the predictability that helps them stay calm and in control,' she told HuffPost UK. 'When there's no clear plan, the uncertainty can quickly lead to anxiety or dysregulation. Transitions become harder, focus drops, and behaviour can spiral.' On top of the sudden shift in routine, there is another huge influence impacting children and their parents during this time: a lack of specialist childcare for SEN (special educational needs) children. A survey from Mencap previously revealed 80% of parents who have children with a learning disability struggle to access support services during the summer holidays. And in 2023, the childcare charity Coram said just one in 20 councils in England had enough childcare available for SEND children during the school holidays. What can parents do to help neurodiverse kids cope over the summer holidays? The biggest takeaway for parents is to stick to a routine, where possible. Dr Warlow explained: 'Feeling anchored is one of the most important coping strategies for them. Simple routines can offer enough structure to help them feel settled, calm, and safe. 'As the summer holidays will change the routine they're used to, setting up a structured day with regular mealtimes, bedtime and short activity blocks are essential.' Autistic children can find surprises 'unsettling and disruptive', according to The Autism Service, while children with ADHD might need more stimulation and can become very restless without planned activities in place. To help them adjust, as well as feel involved and engaged in their new routine, Dr Warlow recommends using visual planners, sand timers and picture schedules. Planning social activities with other children, limiting screen time, and scheduling quiet time might also help to keep meltdowns to a minimum. Related... Waiting Endlessly For ADHD Or Autism Assessment? 'Right To Choose' May Get You Seen Sooner Autism Assessor Reveals 3 Of The 'Most Common' Signs Of Autism In Girls We Have ADHD, So Do Our Kids – Here's How We Get Things Done
Time Business News
2 days ago
- Time Business News
Top Psychiatrists Recommend These ADHD Meds for Anxiety
When it comes to treating anxiety, especially in individuals who also have Attention Deficit Hyperactivity Disorder (ADHD), finding the right medication can be challenging. Many symptoms of anxiety and ADHD overlap, such as restlessness, trouble concentrating, and irritability. Fortunately, top psychiatrists have identified several best adhd medication for adults with anxiety that not only help with focus and hyperactivity but also offer significant relief from anxiety symptoms. Here's a closer look at the top ADHD medications often recommended by psychiatrists for managing anxiety. When managing anxiety or depression, selecting the right medication can significantly influence treatment outcomes. Both medications work by affecting serotonin levels in the brain, yet they have distinct characteristics and side effect profiles. In the comparison of Zoloft vs lexapro, Zoloft may be more energizing and is often used for a broader range of conditions, including OCD and PTSD, while Lexapro is typically favored for its tolerability and fewer interactions. Consulting with a healthcare provider helps determine which option aligns best with individual needs, ensuring a personalized approach to mental health treatment. Strattera is a non-stimulant medication approved by the FDA for the treatment of ADHD. Unlike traditional stimulants, Strattera works by selectively inhibiting the reuptake of norepinephrine, a neurotransmitter involved in attention and emotional regulation. Because it doesn't act on dopamine in the same way as stimulants, it carries a lower risk of dependency and is often favored for patients with co-occurring anxiety disorders. Psychiatrists often recommend Strattera for individuals with generalized anxiety disorder (GAD) alongside ADHD because it provides cognitive benefits without worsening anxiety. Many patients find that Strattera helps improve focus while also easing symptoms such as worry, excessive fear, and physical tension. Originally developed as a treatment for high blood pressure, Intuniv has been repurposed as a non-stimulant ADHD medication, especially effective in children and adolescents. It works by activating alpha-2A adrenergic receptors in the brain, which help regulate attention, impulsivity, and emotional responses. What sets Intuniv apart is its calming effect. Psychiatrists often prescribe it for patients who experience high levels of emotional reactivity or stress. It can reduce anxiety symptoms like nervousness, sleep problems, and irritability, making it a popular choice for patients with both ADHD and anxiety. Kapvay, an extended-release form of clonidine, is another non-stimulant option used to treat ADHD, especially in younger patients. Like Intuniv, Kapvay affects the alpha-2 adrenergic receptors, helping to improve attention while also reducing hyperactivity and impulsive behaviors. Clonidine's sedative properties are particularly beneficial for patients with anxiety-related insomnia. Psychiatrists often recommend Kapvay for individuals who struggle with restlessness, racing thoughts, and trouble sleeping. Because it has a dual effect—calming the body and mind—it's frequently used in patients whose anxiety is physically overwhelming. Though primarily an antidepressant, Wellbutrin is sometimes used off-label for ADHD treatment. It functions as a norepinephrine-dopamine reuptake inhibitor (NDRI), increasing the levels of both neurotransmitters in the brain. This dual action can enhance focus and reduce symptoms of depression and anxiety. Wellbutrin is favored by psychiatrists for patients who have mild to moderate ADHD symptoms along with anxiety or depression. It doesn't carry the same side effect profile as stimulants and can be a good alternative for individuals who are sensitive to traditional ADHD medications or who have a history of substance use disorders. Vyvanse is a stimulant that is commonly prescribed for moderate to severe ADHD. While stimulants are often thought to worsen anxiety, this is not always the case. Many patients report that treating their ADHD symptoms with Vyvanse leads to an overall reduction in anxiety because they can focus better and manage daily tasks more effectively. Psychiatrists may recommend Vyvanse for patients whose anxiety is primarily a result of unmanaged ADHD. By improving executive function and reducing mental clutter, Vyvanse helps some individuals feel more in control, which indirectly reduces anxiety. However, it must be prescribed cautiously, as it can sometimes increase nervousness or insomnia in sensitive individuals. Adderall XR is another stimulant that combines two amphetamine salts to target the dopamine and norepinephrine systems in the brain. Like Vyvanse, it's often prescribed for patients with ADHD and co-occurring anxiety—especially when anxiety is secondary to the distress caused by disorganization, forgetfulness, or impulsivity. Top psychiatrists emphasize the importance of careful monitoring when using Adderall XR in patients with anxiety. While it can lead to significant improvements in focus and performance, it may also cause jitteriness or increased heart rate. For this reason, lower starting doses and close follow-ups are essential. The decision to use a particular ADHD medication to manage anxiety depends on a variety of factors, including the severity of each condition, the patient's medical history, age, and potential for substance misuse. Non-stimulants are often preferred when anxiety is severe or pre-existing. Stimulants can be helpful when ADHD symptoms are driving the anxiety, but they require more careful titration and supervision. It's also important to note that medication is just one piece of the puzzle. Psychiatrists often recommend combining pharmacological treatment with cognitive behavioral therapy (CBT), mindfulness practices, and lifestyle modifications for the best outcomes. Diet, sleep, and exercise all play crucial roles in regulating mood and attention. Top psychiatrists understand that treating ADHD and anxiety together requires a balanced and thoughtful approach. While medications like Strattera, Intuniv, Kapvay, Wellbutrin, Vyvanse, and Adderall XR all offer potential benefits, the best choice depends on the individual's unique profile. A comprehensive evaluation by a licensed psychiatrist is essential for selecting the most effective and safest option. With the right treatment plan in place, many patients experience significant relief from both ADHD and anxiety symptoms—leading to better focus, improved emotional regulation, and a higher quality of life. TIME BUSINESS NEWS
